Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Rashidian

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature Biotechnology|July 30, 2024
A CAR enhancer increases the activity and persistence of CAR T cellsTaha Rakhshandehroo, Shreya R Mantri, Heydar Moravej, et al.
Journal for Immunotherapy of Cancer|February 18, 2026
Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2RαHeydar Moravej, Taha Rakhshandehroo, Radia M M Khan, et al.
JACC. Basic to Translational Science|August 7, 2023
Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction ModelsAlexander Maier, Yohana C Toner, Jazz Munitz, et al.
Research Square|April 3, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapyWillem Mulder, Tom Anbergen, Yuri van Elsas, et al.
Cell|October 30, 2020
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint InhibitionBram Priem, Mandy M T van Leent, Abraham J P Teunissen, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature Biotechnology|July 30, 2024
A CAR enhancer increases the activity and persistence of CAR T cellsTaha Rakhshandehroo, Shreya R Mantri, Heydar Moravej, et al.
Journal for Immunotherapy of Cancer|February 18, 2026
Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2RαHeydar Moravej, Taha Rakhshandehroo, Radia M M Khan, et al.
JACC. Basic to Translational Science|August 7, 2023
Multiparametric Immunoimaging Maps Inflammatory Signatures in Murine Myocardial Infarction ModelsAlexander Maier, Yohana C Toner, Jazz Munitz, et al.
Research Square|April 3, 2026
Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapyWillem Mulder, Tom Anbergen, Yuri van Elsas, et al.
Cell|October 30, 2020
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint InhibitionBram Priem, Mandy M T van Leent, Abraham J P Teunissen, et al.
Pageof 6